Skip to main content
Clinical Trials/CTRI/2018/01/011573
CTRI/2018/01/011573
Completed
Phase 2

A Clinical Study to Evaluate The Efficacy Of Vamana Karma In The Management Of Dyslipidemia

Rishikul Campus Uttarakhand Ayurved University Haridwar0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- obese patient dyslipidemia
Sponsor
Rishikul Campus Uttarakhand Ayurved University Haridwar
Enrollment
40
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 5, 2018
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Rishikul Campus Uttarakhand Ayurved University Haridwar

Eligibility Criteria

Inclusion Criteria

  • 1\.S.Cholesterol \- \> 200 mg/dl
  • 2\.S.Triglyceride \- \> 150 mg/dl
  • 3\.S. LDL \- \> 110 mg/dlNCEP
  • 4\.S.VLDL \- \> 41 mg/dlATP III Guidelines
  • 5\. CHO/HDL Ratio \- \>4\.97 mg/dl
  • 6\.LDL/HDL Ratio \- \>3\.55 mg/dl11
  • 7\.Patient having any one the above criteria
  • 8\.Patients fit for Vamana Karma

Exclusion Criteria

  • 1\.Age \< 20 years or \> 60 years
  • 2\.Patients having serious cardiac ailments as\- Myocardial Infarction, malignant hypertension, cardiac failure.
  • 3\.Patients with clear diagnosis of DM Type I and type II.
  • 4\.Patients having disordered KFT or renal markers.
  • 5\.Patients having untreated Thyroid Disorders.
  • 6\.Drug induced Hyperlipidemia e.g. \- Glucocorticoid induced.
  • 7\.Pregnant and lactating females.

Outcomes

Primary Outcomes

Not specified

Similar Trials